Loading...
NPI 1437605615 · Charleston, SC · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Phi Life Sciences LLC is a clinical medical laboratory provider located in Charleston, South Carolina. This profile covers 36 Medicare and 22 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Phi Life Sciences LLC |
| Address | 645 Meeting St |
| City | Charleston |
| State | SC |
| ZIP | 29403 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | August 29, 2016 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $374.7K |
| Medicare | $91.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
36 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 240 | $140 | $34K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 180 | $110 | $20.2K |
| 86413 | The lab analyst performs an immunoassay to quantify the level of antibodies to the SARS–CoV–2 virus in the patient specimen, such as blood. | 230 | $40 | $9.6K |
| 86409 | The lab analyst performs the technical lab test to analyze the titer (concentration) of neutralizing antibodies in a specimen such as plasma. The level of these antibodies indicates a past infection… | 80 | $80 | $5.9K |
| 81225 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily C, polypeptide 19, also known as CYP2C19. | 10 | $290 | $4K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 40 | $60 | $2.4K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 110 | $20 | $1.7K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 160 | $10 | $1.6K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 30 | $50 | $1.5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 20 | $70 | $1.2K |
Showing 1–10 of 36
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 36 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
36 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| U0004 | 5 | 10 | 150 | $70 | $136.4K |
| G2023 | 4 | 10 | 2,620 | $20 | $58.8K |
| U0005 | 8 | 10 | 320 | $20 | $43.1K |
| 81225 | 2 | 10 | 110 | $290 | $30.8K |
| 80307 | 103 | 130 | 110 | $60 | $14.6K |
| G0480 | 13 | 50 | 90 | $110 | $13.8K |
| 87086 | 21 | 30 | 60 | $10 | $11.6K |
| 86413 | 1 | 10 | 230 | $40 | $9.6K |
| 87637 | 3 | 100 | 40 | $140 | $9.4K |
| 80061 | 237 | 370 | 150 | $10 | $6.7K |
Showing 1–10 of 36
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
22 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 1,730 | $120 | $200.9K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 1,210 | $90 | $111K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,980 | $10 | $25.7K |
| 86413 | The lab analyst performs an immunoassay to quantify the level of antibodies to the SARS–CoV–2 virus in the patient specimen, such as blood. | 420 | $60 | $23.3K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 770 | $10 | $4.6K |
| 81226 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily D, polypeptide 6, also known as CYP2D6. | 120 | $10 | $1K |
| 86409 | The lab analyst performs the technical lab test to analyze the titer (concentration) of neutralizing antibodies in a specimen such as plasma. The level of these antibodies indicates a past infection… | 150 | $10 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 70 | $10 | $960 |
| 81225 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily C, polypeptide 19, also known as CYP2C19. | 140 | $10 | $710 |
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 230 | $1 | $700 |
Showing 1–10 of 22
How this provider's Medicaid billing volume and revenue compare to other South Carolina providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. South Carolina median
22 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81406 | The lab analyst performs the technical lab test to complete one of the specific genetic analyses listed in this Tier 2, Level 7 molecular pathology code. | 2 | 10 | 60 | $760 | $379K |
| 87637 | The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)… | 22 | 60 | 540 | $110 | $271.5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 7 | 20 | 990 | $80 | $159.1K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 74 | 170 | 500 | $50 | $128.5K |
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 3 | 10 | 360 | $130 | $113.7K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 43 | 60 | 300 | $40 | $60K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 20 | 70 | 370 | $30 | $52.1K |
| 86413 | The lab analyst performs an immunoassay to quantify the level of antibodies to the SARS–CoV–2 virus in the patient specimen, such as blood. | 1 | 10 | 420 | $60 | $23.3K |
| 81226 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily D, polypeptide 6, also known as CYP2D6. | 3 | 10 | 140 | $20 | $10.3K |
| 81225 | The lab analyst performs the technical lab test to detect the presence of common changes in the gene for cytochrome P450, family 2, subfamily C, polypeptide 19, also known as CYP2C19. | 3 | 10 | 150 | $10 | $6.2K |
Showing 1–10 of 22
Other providers in the same ZIP code as Phi Life Sciences LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Disabilities Board Of Charleston County | SC | Developmentally Disabled Services Day Training Agency | $0 | $49.9M |
| Vikor Scientific, LLC | SC | Clinical Medical Laboratory | $516.8K | $27M |
| Fetter Health Care Network, Inc. | SC | Federally Qualified Health Center (FQHC) | $0 | $5.8M |
| Nathan Seng | SC | Dentist | $0 | $1.6M |
| Charleston Pathology, P.A. | SC | Clinical Medical Laboratory | $248.5K | $385.5K |
| Alexander Kent | SC | Ophthalmology Physician | $287.4K | $0 |
| Tracy Tipton | SC | Urology Physician | $249.8K | $0 |
| John Mitchell | SC | Critical Care Medicine (Internal Medicine) Physician | $216.5K | $0 |
| Joseph Lally | SC | Ophthalmology Physician | $202.5K | $0 |
| Todd Joye | SC | Interventional Pain Medicine Physician | $192.7K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.